Pfizer Secures $1.5B Blackstone Funding for Obesity Drug
New York, New York, U.S., and Cambridge, Massachusetts, U.S., November 11, 2026 Pfizer Inc. and Blackstone Life Sciences have...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
New York, New York, U.S., and Cambridge, Massachusetts, U.S., November 11, 2026 Pfizer Inc. and Blackstone Life Sciences have...
Aurora, Colorado, U.S., November 11, 2026 Researchers from the University of Colorado Anschutz Medical Campus (CU Anschutz) have published...
Hong Kong, China, November 11, 2026 Ascletis Pharma Inc. has announced the submission of an Investigational New Drug (IND)...
Montreal, Quebec, Canada, November 11, 2026 AI4Eyes Medical Technologies Inc. has announced the successful completion of U.S. Food and...
Thousand Oaks, California, U.S., November 11, 2026 Amgen has announced positive results from its Phase 3 OASIZ-301 clinical trial...
Indianapolis, Indiana, United States, November 11, 2026 Eli Lilly and Company has announced detailed 52-week Phase 3b clinical results...
Milford, Massachusetts, United States, November 10, 2026 Waters Corporation has announced that two ready-to-use flow cytometry clinical tests from...
Salt Lake City, Utah, United States, November 10, 2026 Lipocine Inc., a specialty pharmaceutical company focused on developing innovative...
Copenhagen, Denmark, November 10, 2026 Adcendo ApS, a clinical-stage biotechnology company focused on developing next-generation antibody-drug conjugates (ADCs) for...
Branford, Connecticut, United States, November 10, 2026 Azitra, Inc., a clinical-stage biotechnology company focused on precision dermatology and innovative...
